Pharmaceutical Microbiology East Coast Conference

Drawing on the huge success of SMi’s Pharmaceutical Microbiology event series, SMi is delighted to announce the launch of Pharmaceutical Microbiology East Coast. Being the eighth in its series, this event will take place in New Jersey, USA, on November 13th and 14th 2017. Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology East Coast 2017 will address the best practices for rapid microbial and sterility testing and tackle the challenges of contamination control.

Pharmaceutical Microbiology East Coast has been produced with a vision of promoting the field of microbiology, and has been tailored to address the current issues and opportunities the industry faces every day. Topics of interest will include:
• The role of microbiology in pharmaceutical stability programs
• Deciphering the host-microbe interaction
• Benefits of real-time monitoring of airborne viable microorganisms
• Current expectations for a complete environmental monitoring program
• Quality control strategy on low endotoxin recovery (LER)
• Implementation of a global electronic intervention logging system
Chairs for 2017:
• Somduttan Saha, Post-Doctoral Scientist, Glaxosmithkline
• Geeta Singh, Pilot Plant Technical Specialist III, Genentech
Expert Speaker Line-Up Includes:
• Andrew Bartko, Research Leader, Battelle Memorial Institute
• Brian Hubka, CEO, BGH International
• Shawn Sweeney, Senior Process Development Manager, Charles River
• Frederic Ayers, Consultant Scientist, Sterility Assurance, Eli Lilly And Company
• Shahram Lavasani, CEO, ImmuneBiotech AB
• James Hauschild, Principal Scientist, Johnson & Johnson
• Tony Cundell, Principal Consultant, Microbiological Consulting, LLC
• David Huang, Chief Medical Officer, Motif BioSciences
• Tony Van Hoose, Director, Sterile Technologies Expertise, Sanofi
• Jim Polarine, Senior Technical Service Manager, STERIS Corporation
• Joseph Chen, Executive Director, CMC Quality Control, Ultragenyx Pharmaceutical

Exclusive highlights in 2017:

• Discuss training of media fill inspection operators with Sanofi
• Decipher the Host-Microbe interaction with GlaxoSmithKline
• Hear Eli Lilly’s keynote address on Implementation of a global electronic intervention logging system
• Understand the role of microbiology in pharmaceutical stability programs with Microbiological Consulting, LLC
• Delve into the current expectations for a complete environmental monitoring program with Excellent Pharma Consulting

Other event highlights include TWO exclusive post-conference interactive workshops carefully selected to enhance your conference experience and encourage personal and professional development. Places are strictly limited to ensure optimal learning for attendees.

Workshop A – Navigating the requirements of a modern QC Microbiology Laboratory
Wednesday 15th November 2017 | 08.30 – 12.30
Workshop Leaders: Quality Executive Partners, Inc.

Workshop B – Contamination Control in Cleanrooms
Wednesday 15th November 2017 | 13.30 – 17.30
Workshop Leader: STERIS Corporation


Previous attendees included:

Abbott Biologicals; Abbott Biologicals B V; Abbott Biologicals B.V; Astrazeneca; Atheris Laboratories; BD Life Sciences; BPL; Clean Air and Containment Review; Confarma France S A R L; Debiopharm Research & manufacturing SA; Dyson Technology Ltd; GE Healthcare; GSK; GSK Manufacturing S.p.A.; GW Pharmaceuticals; Hyglos GmbH; iDev; IDEXX Technologies Limited; Innaxon; International Confederation of Contamination Control Societies ; London Research Institute; Lonza Biologics Plc; Lonza Incorporated; Martindale Pharmaceuticals; MedImmune; Merck; Merck Chemicals Ltd; Merial; Merial Sas; Merial Saude Animal Ltda; Mettler-Toledo Ltd; MSD Animal Health; Nestle Research Center; Nova Laboratories; Novartis Vaccines; Oxford BioMedica; Pharmig; PHSS; Public Health England; Queen’s University, Kingston, Ontario; Sanofi Pharma; Sanofi-Aventis; Sigma Aldrich; STERIS Corporation; Teva UK Ltd; Trafalgar Scientific Ltd.; University of Southampton; Vetter Pharma-Fertigung GmbH & Co. KG; Wickham Laboratories Ltd


Pharmaceutical Microbiology East Coast attendees will have access to network with companies across the complete pharma supply chain. With its unique blend of unprecedented global influence and the infrastructure to advance relationships between buyers and sellers, Microbiology East Coast 2017 will provide a platform of solutions and ideas unlike any other.

Go to event website